For investor-related information please contact Ronn Bechler at Automic Group Ph: +61 (0) 400 009 774 E: ronn.bechler@automicgroup.com.au
Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC
Some excerpt
Presentation – ASX Small and Mid-Cap Conference
Start typing and press Enter to search